Latest News and Press Releases

BEIJING, Feb. 02, 2026 (GLOBE NEWSWIRE) -- KANZHUN LIMITED (“BOSS Zhipin” or the “Company”) (Nasdaq: BZ; HK: 2076) today announced the continued execution of its share repurchase program, utilizing...

27,182 vehicles were delivered in January 2026, increasing by 96.1% year-over-yearCumulative deliveries reached 1,024,774 as of January 31, 2026   SHANGHAI, Feb. 01, 2026 (GLOBE NEWSWIRE) -- NIO...

BEIJING, China, Feb. 01, 2026 (GLOBE NEWSWIRE) -- Li Auto Inc. (“Li Auto” or the “Company”) (Nasdaq: LI; HKEX: 2015), a leader in China’s new energy vehicle market, today announced that it delivered...

SHANGHAI, China, Jan. 30, 2026 (GLOBE NEWSWIRE) -- GDS Holdings Limited (“GDS Holdings”, “GDS” or the “Company”) (NASDAQ: GDS; HKEX: 9698), a leading developer and operator of high-performance data...

SHENZHEN, CHINA, Jan. 30, 2026 (GLOBE NEWSWIRE) -- China Medical System Holdings Limited (“CMS” or the “Group”) is pleased to announce that its subsidiary, Dermavon Holdings Limited (“Dermavon”, an...

BEIJING, Jan. 29, 2026 (GLOBE NEWSWIRE) -- KANZHUN LIMITED (“BOSS Zhipin” or the “Company”) (Nasdaq: BZ; HK: 2076) today announced the continued execution of its share repurchase program, utilizing...

Soficitinib demonstrated a favorable safety profile and encouraging efficacy in treating patients with moderate-to-severe AD.

WeRide today launched WeRide GENESIS, its proprietary general simulation model designed to accelerate the development, training, and validation of AVs.

גואנגג'ואו, סין, Jan. 28, 2026 (GLOBE NEWSWIRE) -- WeRide (HKEX: 0800.HK , נאסד"ק: WRD), מובילה עולמית בטכנולוגיית נהיגה אוטונומית, הכריזה על השקת WeRide GENESIS1, מודל ההדמיה למטרות כלליות...

CBT-004, if approved, would be the first and only treatment for pinguecula, an ophthalmic condition impacting more than 50 million people in the U.S. alone In prior studies, CBT-004 demonstrated an...